After Hours: Gapapentin: A Popular and Potentially Troublesome Medicine (From the Archives)
Gabapentin has quietly become one of the most widely-prescribed drugs in America, and some say that could spell big trouble.
Michael Abrams
(WATCH) Gabapentin’s popularity and off-label usage
(Originally aired: Dec. 4, 2022) Today we begin with a medicine that has quietly become one of the most widely-prescribed drugs in America, gabapentin. It’s most often given for illnesses it wasn’t FDA-approved to treat. That practice is legal, but
(WATCH) Gabapentin’s popularity and off-label usage Read More »
(READ) Watchdogs want FDA to reject fast-tracking of new gene therapy treatment
Public Citizen’s Health Research Group wants the FDA to deny speeded up approval of a new gene therapy treatment. The advocacy group states that the treatment, SRP-9001 (Sarepta Therapeutics) for ambulatory Duchenne muscular dystrophy (DMD), intended for children aged four
(READ) Watchdogs want FDA to reject fast-tracking of new gene therapy treatment Read More »
(WATCH) The off label usage of Gabapentin
Today we begin with a medicine that has quietly become one of the most widely-prescribed drugs in America, gabapentin. It’s most often given for illnesses it wasn’t FDA-approved to treat. That practice is legal, but some watchdogs say gabapentin’s allegedly
Full Measure After Hours: Gabapentin – a popular and potentially troublesome medicine (Podcast)
Gabapentin has quietly become one of the most widely-prescribed drugs in America, and some say that could spell big trouble. Michael Abrams of Public Citizen explains why, as neurologist Dr. Brian Callaghan offers a counterpoint.
